From outbreak investigations to clinical trials, the right study design can make or break public health research. Understanding the strengths, limitations, and applications of each approach helps ...

The head of the CDC invented a new standard to stop the publication of studies showing COVID-19 vaccines had major benefits with minimal risk.

Critical appraisal is the backbone of evidence-based practice, helping clinicians, researchers, and students separate trustworthy studies from flawed ones. From understanding epidemiological study ...

Researchers hoped results from the latest trial on low-dose lithium would settle the question of lithium’s potential to ...

Increased risk for hypertensive disorders was present, but modest, in a new surveillance analysis of a bivalent respiratory syncytial virus (RSV) prefusion F subunit-based (RSVpreF) vaccine for ...

Strategic investment brings together RTI's scientific leadership and Navidence AI-native platform to improve research quality, reproducibility, and patient outcomes across the lif ...

Carnegie Mellon University has named six faculty members as University Professors, recognizing their exceptional contributions to research, education and interdisciplinary collaboration.

Onco-Innovations announces Inka Health enters collaborative research agreement with GSK: Vancouver, Canada Thursday, May 7, 2026, 15:00 Hrs [IST] Onco-Innovations Limited, a Canad ...

Desai, MBBS, MD, assistant professor of thoracic medical oncology/head and neck medical oncology at Fox Chase Cancer Center ...

Read more about Artificial intelligence could become operating system of future healthcare systems on Devdiscourse ...

VANCOUVER, BC / ACCESS Newswire / May 5, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that Inka Health Corp.